LyndaASzczechMD
Nephrology • Durham, NCVice President of Clinical Development, Fibrogen, San Francisco CA
Dr. Szczech is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3 Waterview Ct
Durham, NC 27703- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1994 - 1996
Duke University HospitalResidency, Internal Medicine, 1991 - 1994
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1991
Certifications & Licensure
CA State Medical License 2024 - 2026
MN State Medical License 2024 - 2025
NC State Medical License 1993 - 2025
NY State Medical License 1997 - 2023
PA State Medical License 1995 - 1997- American Board of Internal Medicine Nephrology
Clinical Trials
- Optimal Treatment for Kidney Disease in HIV Infected Adults
- Erythropoietin Resistance in Anemia of Chronic Kidney Disease Start of enrollment: 2007 Aug 01
- How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsChanges in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.Pablo E Pergola, Chaim Charytan, Dustin J Little, Stefan Tham, Lynda Szczech, Robert Leong, Steven Fishbane> ;Kidney360. 2022 Sep 29
- Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.". 2021;6:613-623.Robert Provenzano, Steven Fishbane, Lynda Szczech, Robert Leong, Khalil G Saikali, Ming Zhong, Tyson T Lee, Mark T Houser, Lars Frison, John Houghton, Dustin J Little,...> ;Kidney International Reports. 2022 Mar 1
- 36 citationsEfficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.Robert Provenzano, Lynda A. Szczech, Robert Leong, Khalil G. Saikali, Ming Zhong, Tyson Lee, Dustin J. Little, Mark T. Houser, Lars Frison, John Houghton, Thomas B. Neff> ;Clinical Journal of the American Society of Nephrology. 2021 Aug 1
- Join now to see all
Press Mentions
- Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 StudyFebruary 11th, 2021
Grant Support
- Analysis Of Associations Between Anemia Correction In CKD And MORTALITY: ChoirNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
- An Observational Study Of The Pharmacokinetics Of Efavirenz, Nevirapine, And LOPNational Center For Research Resources2005
- Epidemiology And Clinical Course Of HIV NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
